8-K: FOXO Technologies to Acquire Healthcare Assets from Rennova Health in Share Exchange Deal

FOXO Technologies is set to acquire Myrtle Recovery Centers and Rennova Community Health, including Big South Fork Medical Center, from Rennova Health in a share exchange agreement valued at approximately $20.5 million.

Summary

• FOXO Technologies has agreed to acquire two healthcare entities from Rennova Health through separate share exchange agreements.
• The first agreement involves FOXO acquiring Myrtle Recovery Centers, a behavioral health services subsidiary, for $500,000 in FOXO common stock, subject to potential adjustments based on EBITDA.
• The second agreement entails FOXO acquiring Rennova Community Health, which owns Big South Fork Medical Center, a critical access hospital, for $20 million in FOXO convertible preferred stock, also subject to EBITDA adjustments.
• Myrtle Recovery Centers and Scott County Community Hospital generated approximately $18.7 million in revenue and $5.2 million in net income for the twelve months ended December 31, 2023.
• The closing of these transactions is contingent upon certain conditions, including shareholder approval for the Rennova Community Health acquisition and securing a $2.5 million funding agreement for FOXO.
• The agreements include provisions for adjustments to the purchase price based on the audited EBITDA of the acquired entities, with changes reflected in additional shares or cash payments.
• FOXO aims to integrate its epigenetic technology with the acquired healthcare operations to improve patient outcomes and expand its market reach.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the strategic benefits and growth opportunities of the acquisitions. However, there are some risks and uncertainties associated with the transactions, which temper the overall sentiment.

Positives

• The acquisitions are expected to bring significant cash flow to FOXO.
• The integration of FOXO's epigenetic technology with the acquired healthcare operations is expected to improve patient outcomes.
• The acquisitions provide FOXO with established businesses with opportunities for continued growth.
• Rennova's expertise in healthcare IT and software creates additional opportunities for FOXO.
• The agreements include rights for FOXO to expand the acquired businesses into another East Tennessee property owned by Rennova.

Negatives

• The purchase price for both acquisitions is subject to adjustments based on the audited EBITDA of the acquired entities, which could result in a lower valuation.
• The closing of the Myrtle Recovery Centers acquisition is contingent on securing a $2.5 million funding agreement for FOXO, which may not be guaranteed.
• The closing of the Rennova Community Health acquisition is subject to shareholder approval of FOXO, which may not be guaranteed.

Risks

• The acquisitions are subject to closing conditions, including shareholder approval and securing a funding agreement, which may not be met.
• The purchase price is subject to adjustments based on EBITDA, which could impact the final valuation.
• There is a risk that the integration of the acquired businesses may not be successful.
• There is a risk that the expected synergies and growth opportunities may not materialize.
• The agreements include a potential rescission clause if FOXO receives a delisting notice within four months of closing.

Future Outlook

FOXO plans to grow the revenues of the acquired businesses and leverage Rennova's expertise in diagnostic testing and healthcare IT. The company aims to combine its epigenetic solutions with the acquired healthcare services to bring an unprecedented level of care to patients.

Management Comments

• Mark White, Interim CEO of FOXO Technologies, stated that the acquisition represents a transformative step for FOXO and brings meaningful cash flow.
• Seamus Lagan, the Chief Executive Officer of Rennova Health Inc., expressed delight in entering into the transactions with FOXO and believes it will drive significant value and synergies for both companies.

Industry Context

This announcement reflects a trend of biotechnology companies expanding into healthcare services to leverage their technologies and generate revenue. The acquisition of a critical access hospital and a behavioral health facility aligns with the growing focus on community health and addiction recovery.

Comparison to Industry Standards

• The acquisition of a critical access hospital by a biotechnology company is not a common occurrence, making this a unique transaction.
• The valuation of the acquisitions is based on EBITDA, which is a standard practice in healthcare acquisitions.
• The use of convertible preferred stock in the Rennova Community Health acquisition is a common method for financing acquisitions.
• The revenue and net income figures for the acquired entities are within the range of similar healthcare facilities in the region.
• The focus on integrating epigenetic technology with healthcare services is a novel approach that could differentiate FOXO from its competitors.

Stakeholder Impact

• Shareholders of FOXO may see increased value through the acquisition of profitable healthcare businesses.
• Employees of Myrtle Recovery Centers and Big South Fork Medical Center may experience changes in their roles and responsibilities.
• Patients of the acquired healthcare facilities may benefit from the integration of FOXO's epigenetic technology.
• Creditors of FOXO may be impacted by the new debt and equity structure.
• Suppliers of the acquired healthcare facilities may see changes in their contracts and relationships.

Next Steps

• FOXO and Rennova will seek shareholder approval for the Rennova Community Health acquisition.
• FOXO will work to secure a $2.5 million funding agreement.
• The parties will work to satisfy all closing conditions.
• FOXO will integrate the acquired businesses into its operations.
• FOXO will file a proxy statement with the SEC regarding the acquisition of Rennova Community Health.

Key Dates

Keywords

FOXO Technologies, Rennova Health, Myrtle Recovery Centers, Rennova Community Health, Big South Fork Medical Center, share exchange, acquisition, healthcare, epigenetic technology, EBITDA, convertible preferred stock, behavioral health, critical access hospital